Gilead Sciences: The M&A Question

From Stocks To Watch Today
January 11, 2017 - 3:46pm

JPMorgan is hosting its health care conference this week, which has provided opportunities for companies to provide updates on their pipelines, profits and even M&A plans before a captive audience. And of course, Gilead Sciences (GILD) was there, and its management spoke to analysts about its business, including the possibility for...M&A, which we don't need to remind you is much on investors' minds. Mizuho's Salim Syed offered his takeaway on the subject:



Continue reading this article »